- Over the Counter (OTC) drugs, which are medications available without a prescription, are increasingly vital components of global healthcare systems due to their accessibility, cost-effectiveness, and role in promoting self-care for common health issues such as colds, allergies, gastrointestinal problems, and pain management
- The escalating demand for OTC drugs is primarily fueled by growing consumer awareness of health and wellness, increased self-medication trends, and expanded availability of these products through online and retail pharmacies
- North America dominates the over the counter (OTC) drugs market with the largest revenue share of 38.3% in 2024, characterized by mature healthcare infrastructure, high consumer awareness, and widespread availability of OTC products across well-established retail chains and e-commerce platforms
- Asia-Pacific is expected to be the fastest growing region in the over the counter (OTC) drugs market during the forecast period due to a rising middle-class population, improving healthcare access, and an expanding pharmacy retail network, particularly in countries such as China and India
- Cold, cough and flu products segment dominates the over the counter (OTC) drugs market with a market share of 26% in 2024, driven by the seasonal prevalence of respiratory infections and the consistent demand for symptomatic relief, further amplified by pandemic-related health consciousness and product innovations
